Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 13, 2010Clinical Cancer ResearchOpen Access

The Cross-Validated Adaptive Signature Design

View Full Paper
Ask AI
Bookmark
Share

Authors

BFBoris FreidlinWJWenyu JiangRSRichard Simon

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Freidlin et al. (2010) studied this question.

synapsesocial.com/papers/6a6fc13435aa2c282ce1186bhttps://doi.org/10.1158/1078-0432.ccr-09-1357
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolution of Anticancer Drug Discovery and the Role of Cell-Based Screening2002 · 84 citations
  2. 2Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients2005 · 348 citations
  3. 3Bias in error estimation when using cross-validation for model selection2006 · 2,345 citations
  4. 4Prediction error estimation: a comparison of resampling methods2005 · 1,370 citations
  5. 5Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification2003 · 1,018 citations